Abstract
Androgen signalling is the primary driver of male sexual differentiation in mammals, directing masculinization during a crucial fetal window. In male fetuses, high levels of fetal androgens, mainly from the testes, promote male reproductive tract development through androgen receptor activation, whereas low levels of androgens in female fetuses enable the development along the female pathway. This androgen-centric view of reproductive development has long dominated the field, casting oestrogens as passive bystanders. However, both historical and emerging evidence challenges this narrative, pointing to an active role of oestrogens in shaping reproductive development through complex, tissue-specific interactions with androgen pathways. Oestrogen receptors are expressed in developing reproductive tissues of both sexes, and disruptions in oestrogen signalling — shown in genetic and pharmacological models — can lead to reproductive abnormalities. Oestrogens might counteract androgen action at the tissue level and modulate androgen receptor expression, independently of effects on androgen production. Moreover, combined exposure to anti-androgens and oestrogenic compounds can amplify developmental disruptions, underscoring the importance of hormonal crosstalk. These findings question the adequacy of an androgen-only model, especially when assessing endocrine disruptors. Understanding the role of oestrogens is essential for interpreting normal development and chemical risks. Reproductive differentiation seems to depend on the integrated balance between androgen and oestrogen pathways, rather than on isolated signals.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout


Similar content being viewed by others
References
Jiménez, R., Burgos, M. & Barrionuevo, F. J. Sex maintenance in mammals. Genes 12, 999 (2021).
Wilhelm, D., Palmer, S. & Koopman, P. Sex determination and gonadal development in mammals. Physiol. Rev. 87, 1–28 (2007).
Sharpe, R. M. Androgens and the masculinization programming window: human–rodent differences. Biochem. Soc. Trans. 48, 1725–1735 (2020).
Hughes, I. A. Minireview: sex differentiation. Endocrinology 142, 3281–3287 (2001).
Hess, R. A., Sharpe, R. M. & Hinton, B. T. Estrogens and development of the rete testis, efferent ductules, epididymis and vas deferens. Differentiation 118, 41–71 (2021).
Wiesner, B. P. The post-natal development of the genital organs in the albino rat: with a discussion of a new theory of sexual differentiation. BJOG 42, 8–78 (1935).
Greene, R. R. & Ivy, A. C. The experimental production of intersexuality in the female rat with testosterone. Science 86, 200–201 (1937).
Greene, R. R., Burrill, M. W. & Ivy, A. C. Experimental intersexuality: the production of feminized male rats by antenatal treatment with estrogens. Science 88, 130–131 (1938).
Greene, R. R., Burrill, M. W. & Ivy, A. C. Experimental intersexuality: the effects of combined estrogens and androgens on the embryonic sexual development of the rat. J. Exp. Zool. 87, 211–232 (1941).
Josso, N. Professor Alfred Jost: the builder of modern sex differentiation. Sex. Dev. 2, 55–63 (2008).
Burlington, H. & Lindeman, V. F. Effect of DDT on testes and secondary sex characters of white leghorn cockerels. Exp. Biol. Med. 74, 48–51 (1950).
Herbst, A. L., Ulfelder, H. & Poskanzer, D. C. Adenocarcinoma of the vagina. N. Engl. J. Med. 284, 878–881 (1971).
Colborn, T., vom Saal, F. S. & Soto, A. M. Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ. Health Perspect. 101, 378–384 (1993).
Sharpe, R. M. & Skakkebaek, N. E. Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 341, 1392–1396 (1993).
Henderson, B. E., Benton, B., Jing, J., Yu, M. C. & Pike, M. C. Risk factors for cancer of the testis in young men. Int. J. Cancer 23, 598–602 (1979).
Svingen, T. & Koopman, P. Building the mammalian testis: origins, differentiation, and assembly of the component cell populations. Genes Dev. 27, 2409–2426 (2013).
Koopman, P., Münsterberg, A., Capel, B., Vivian, N. & Lovell-Badge, R. Expression of a candidate sex-determining gene during mouse testis differentiation. Nature 348, 450–452 (1990).
Wilhelm, D., Perea-Gomez, A., Newton, A. & Chaboissier, M.-C. Gonadal sex determination in vertebrates: rethinking established mechanisms. Development 152, dev204592 (2025).
Arnold, A. P. A general theory of sexual differentiation. J. Neurosci. Res. 95, 291–300 (2017).
Wilson, J. D. & Lasnitzkp, I. Dihydrotestosterone formation in fetal tissues of the rabbit and rat. Endocrinology 89, 659–668 (1971).
Deslypere, J. P., Young, M., Wilson, J. D. & McPhaul, M. J. Testosterone and 5α-dihydrotestosterone interact differently with the androgen receptor to enhance transcription of the MMTV-CAT reporter gene. Mol. Cell. Endocrinol. 88, 15–22 (1992).
Imperato-McGinley, J., Sanchez, R. S., Spencer, J. R., Yee, B. & Vaughan, E. D. Comparison of the effects of the 5α-reductase inhibitor finasteride and the antiandrogen flutamide on prostate and genital differentiation: dose-response studies. Endocrinology 131, 1149–1156 (1992).
Welsh, M. et al. Identification in rats of a programming window for reproductive tract masculinization, disruption of which leads to hypospadias and cryptorchidism. J. Clin. Invest. 118, 1479–1490 (2008).
Jiali, C., Huifang, P., Yuqing, J., Xiantao, Z. & Hongwei, J. Worldwide cohort study of 46, XY differences/disorders of sex development genetic diagnoses: geographic and ethnic differences in variants. Front. Genet. 15, 1387598 (2024).
Hughes, I. A. et al. Consensus statement on management of intersex disorders. Arch. Dis. Child. 91, 554–563 (2006).
MacLeod, D. J. et al. Androgen action in the masculinization programming window and development of male reproductive organs. Int. J. Androl. 33, 279–287 (2010).
Schwartz, C. L. et al. Anogenital distance as a toxicological or clinical marker for fetal androgen action and risk for reproductive disorders. Arch. Toxicol. 93, 253–272 (2019).
Skakkebaek, N. E. et al. Male reproductive disorders and fertility trends: influences of environment and genetic susceptibility. Physiol. Rev. 96, 55–97 (2016).
van den Driesche, S. et al. Relative importance of prenatal and postnatal androgen action in determining growth of the penis and anogenital distance in the rat before, during and after puberty. Int. J. Androl. 34, e578–e586 (2011).
Prins, G. S. & Putz, O. Molecular signaling pathways that regulate prostate gland development. Differentiation 76, 641–659 (2008).
Rodriguez, E. et al. Specific morphogenetic events in mouse external genitalia sex differentiation are responsive/dependent upon androgens and/or estrogens. Differentiation 84, 269–279 (2012).
Baskin, L. et al. Androgen and estrogen receptor expression in the developing human penis and clitoris. Differentiation 111, 41–59 (2020).
Amato, C. M. & Yao, H. H.-C. Developmental and sexual dimorphic atlas of the prenatal mouse external genitalia at the single-cell level. Proc. Natl. Acad. Sci. USA 118, e2103856118 (2021).
Kitakule, A. S., Amato, C. M. & Yao, H. H.-C. Characterization of urethra closure in female neonatal mice at histological and molecular levels. Reproduction 168, e240239 (2024).
Escobar, J. C., Patel, S. S., Beshay, V. E., Suzuki, T. & Carr, B. R. The human placenta expresses CYP17 and generates androgens de novo. J. Clin. Endocrinol. Metab. 96, 1385–1392 (2011).
Reisch, N. et al. Alternative pathway androgen biosynthesis and human fetal female virilization. Proc. Natl. Acad. Sci. USA 116, 22294–22299 (2019).
O’Shaughnessy, P. J. et al. Alternative (backdoor) androgen production and masculinization in the human fetus. PLoS Biol. 17, e3000002 (2019).
Witchel, S. F. Disorders of sex development. Best. Pract. Res. Clin. Obstet. Gynaecol. 48, 90–102 (2018).
Gregoire, E. P. et al. The -KTS splice variant of WT1 is essential for ovarian determination in mice. Science 382, 600–606 (2023).
Nef, S. et al. Gene expression during sex determination reveals a robust female genetic program at the onset of ovarian development. Dev. Biol. 287, 361–377 (2005).
Kobayashi, A. & Behringer, R. R. Developmental genetics of the female reproductive tract in mammals. Nat. Rev. Genet. 4, 969–980 (2003).
Thornton, J. W., Need, E. & Crews, D. Resurrecting the ancestral steroid receptor: ancient origin of estrogen signaling. Science 301, 1714–1717 (2003).
Eick, G. N. & Thornton, J. W. Evolution of steroid receptors from an estrogen-sensitive ancestral receptor. Mol. Cell. Endocrinol. 334, 31–38 (2011).
Baker, M. E. Steroid receptors and vertebrate evolution. Mol. Cell. Endocrinol. 496, 110526 (2019).
Cunha, G. R., Li, Y., Mei, C., Derpinghaus, A. & Baskin, L. S. Ontogeny of estrogen receptors in human male and female fetal reproductive tracts. Differentiation 118, 107–131 (2021).
Walker, V. R. & Korach, K. S. Estrogen receptor knockout mice as a model for endocrine research. ILAR J. 45, 455–461 (2004).
Antal, M. C., Krust, A. E., Chambon, P. & Mark, M. Sterility and absence of histopathological defects in nonreproductive organs of a mouse ER-null mutant. Proc. Natl Acad. Sci. USA 105, 2433–2438 (2008).
Eddy, E. M. et al. Targeted disruption of the estrogen receptor gene in male mice causes alteration of spermatogenesis and infertility. Endocrinology 137, 4796–4805 (1996).
Lubahn, D. B. et al. Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene. Proc. Natl Acad. Sci. USA 90, 11162–11166 (1993).
Couse, J. F. et al. Postnatal sex reversal of the ovaries in mice lacking estrogen receptors α and β. Science 286, 2328–2331 (1999).
Asadi, M., Ghafouri-Fard, S., Zare-Abdollahi, D., Ebrahim-Habibi, A. & Matin, N. Estrogen receptor mutation in a girl with primary amenorrhea. Clin. Genet. 83, 497–498 (2013).
Smith, E. P. et al. Estrogen resistance caused by a mutation in the estrogen-receptor gene in a man. N. Engl. J. Med. 331, 1056–1061 (1994).
Bernard, V. et al. Familial multiplicity of estrogen insensitivity associated with a loss-of-function ESR1 mutation. J. Clin. Endocrinol. Metab. 102, 93–99 (2016).
Ban, S. et al. Genetic polymorphisms of ESR1 and ESR2 that may influence estrogen activity and the risk of hypospadias. Hum. Reprod. 23, 1466–1471 (2008).
Safarinejad, M. R., Shafiei, N. & Safarinejad, S. Association of polymorphisms in the estrogen receptors alpha, and beta (ESR1, ESR2) with the occurrence of male infertility and semen parameters. J. Steroid Biochem. Mol. Biol. 122, 193–203 (2010).
Xie, Q.-G. et al. 46,XY disorders of sex development: the use of NGS for prevalent variants. Hum. Genet. 141, 1863–1873 (2022).
Wang, H. et al. Next-generation sequencing reveals genetic landscape in 46, XY disorders of sexual development patients with variable phenotypes. Hum. Genet. 137, 265–277 (2018).
Globa, E. et al. Disorders of sex development in a large Ukrainian cohort: clinical diversity and genetic findings. Front. Endocrinol. 13, 810782 (2022).
Hess, R. A. et al. A role for oestrogens in the male reproductive system. Nature 390, 509–512 (1997).
Chen, M. et al. Defects of prostate development and reproductive system in the estrogen receptor-α null male mice. Endocrinology 150, 251–259 (2009).
Prins, G. S. & Korach, K. S. The role of estrogens and estrogen receptors in normal prostate growth and disease. Steroids 73, 233–244 (2008).
Prins, G. S. et al. Estrogen imprinting of the developing prostate gland is mediated through stromal estrogen receptor alpha: studies with alphaERKO and betaERKO mice. Cancer Res. 61, 6089–6097 (2001).
Govers, L. C. et al. A critical role for estrogen signaling in penis development. FASEB J. 33, 10383–10392 (2019).
Cripps, S. M. et al. A loss of estrogen signaling in the aromatase deficient mouse penis results in mild hypospadias. Differentiation 109, 42–52 (2019).
Okumu, L. A., Bruinton, S., Braden, T. D., Simon, L. & Goyal, H. O. Estrogen-Induced maldevelopment of the penis involves down-regulation of myosin heavy chain 11 (MYH11) expression, a biomarker for smooth muscle cell differentiation. Biol. Reprod. 87, 109 (2012).
Zheng, Z., Armfield, B. A. & Cohn, M. J. Timing of androgen receptor disruption and estrogen exposure underlies a spectrum of congenital penile anomalies. Proc. Natl. Acad. Sci. USA 112, E7194–E7203 (2015).
Yang, J. H., Menshenina, J., Cunha, G. R., Place, N. & Baskin, L. S. Morphology of mouse external genitalia: implications for a role of estrogen in sexual dimorphism of the mouse genital tubercle. J. Urol. 184, 1604–1609 (2010).
Akingbemi, B. T. et al. Estrogen receptor-α gene deficiency enhances androgen biosynthesis in the mouse Leydig cell. Endocrinology 144, 84–93 (2003).
Delbès, G. et al. Endogenous estrogens inhibit mouse fetal Leydig cell development via estrogen receptor α. Endocrinology 146, 2454–2461 (2005).
Rago, V., Romeo, F., Giordano, F., Ferraro, A. & Carpino, A. Identification of the G protein-coupled estrogen receptor (GPER) in human prostate: expression site of the estrogen receptor in the benign and neoplastic gland. Andrology 4, 121–127 (2016).
Vaucher, L. et al. Activation of GPER-1 estradiol receptor downregulates production of testosterone in isolated rat Leydig cells and adult human testis. PLoS ONE 9, e92425 (2014).
Otto, C. et al. GPR30 does not mediate estrogenic responses in reproductive organs in mice. Biol. Reprod. 80, 34–41 (2009).
Zimmerman, M. A., Budish, R. A., Kashyap, S. & Lindsey, S. H. GPER–novel membrane oestrogen receptor. Clin. Sci. 130, 1005–1016 (2016).
Sinkevicius, K. W. et al. Estrogen-dependent and -independent estrogen receptor-α signaling separately regulate male fertility. Endocrinology 150, 2898–2905 (2009).
Vorherr, H., Messer, R. H., Vorherr, U. F., Jordan, S. W. & Kornfeld, M. Teratogenesis and carcinogenesis in rat offspring after transplacental and transmammary exposure to diethylstilbestrol. Biochem. Pharmacol. 28, 1865–1877 (1979).
Kim, K. S. et al. Induction of hypospadias in a murine model by maternal exposure to synthetic estrogens. Environ. Res. 94, 267–275 (2004).
Mahawong, P. et al. Prenatal diethylstilbestrol induces malformation of the external genitalia of male and female mice and persistent second-generation developmental abnormalities of the external genitalia in two mouse strains. Differentiation 88, 51–69 (2014).
Sinclair, A. W. et al. Mouse hypospadias: a critical examination and definition. Differentiation 92, 306–317 (2016).
Driscoll, S. G. & Taylor, S. H. Effects of prenatal maternal estrogen on the male urogenital system. Obstet. Gynecol. 56, 537–542 (1980).
Klip, H. et al. Hypospadias in sons of women exposed to diethylstilbestrol in utero: a cohort study. Lancet 359, 1102–1107 (2002).
Kalfa, N., Paris, F., Soyer-Gobillard, M. O., Daures, J. P. & Sultan, C. Prevalence of hypospadias in grandsons of women exposed to diethylstilbestrol during pregnancy: a multigenerational national cohort study. Fertil. Steril. 95, 2574–2577 (2011).
Pons, J. C., Papiernik, E., Billon, A., Hessabi, M. & Duyme, M. Hypospadias in sons of women exposed to diethylstilbestrol in utero. Prenat. Diagn. 25, 418–419 (2005).
Palmer, J. R. et al. Hypospadias in sons of women exposed to diethylstilbestrol in utero. Epidemiology 16, 583–586 (2005).
Palmer, J. R. et al. Urogenital abnormalities in men exposed to diethylstilbestrol in utero: a cohort study. Environ. Health 8, 37 (2009).
Rogers, R. E., Fowler, K. A., Pask, A. J. & Mattiske, D. M. Prenatal exposure to diethylstilbestrol has multigenerational effects on folliculogenesis. Sci. Rep. 14, 30819 (2024).
Jefferies, J. A. et al. Structural anomalies of the cervix and vagina in women enrolled in the Diethylstilbestrol Adenosis (DESAD) Project. Am. J. Obstet. Gynecol. 148, 59–66 (1984).
Rouiller-Fabre, V. et al. Nuclear receptors and endocrine disruptors in fetal and neonatal testes: a gapped landscape. Front. Endocrinol. 6, 58 (2015).
Pask, A. J. A role for estrogen in somatic cell fate of the mammalian gonad. Chromosome Res. 20, 239–245 (2012).
Trukhina, A. V., Lukina, N. A., Wackerow-Kouzova, N. D. & Smirnov, A. F. The variety of vertebrate mechanisms of sex determination. Biomed. Res. Int. 2013, 587460 (2013).
Durando, M. et al. Neonatal expression of amh, sox9 and sf-1 mRNA in Caiman latirostris and effects of in ovo exposure to endocrine disrupting chemicals. Gen. Comp. Endocrinol. 191, 31–38 (2013).
Lambeth, L. S., Cummins, D. M., Doran, T. J., Sinclair, A. H. & Smith, C. A. Overexpression of aromatase alone is sufficient for ovarian development in genetically male chicken embryos. PLoS ONE 8, e68362 (2013).
Barske, L. A. & Capel, B. Estrogen represses SOX9 during sex determination in the red-eared slider turtle Trachemys scripta. Dev. Biol. 341, 305–314 (2010).
Pask, A. J., Calatayud, N. E., Shaw, G., Wood, W. M. & Renfree, M. B. Oestrogen blocks the nuclear entry of SOX9 in the developing gonad of a marsupial mammal. BMC Biol. 8, 113 (2010).
Uhlenhaut, N. H. et al. Somatic sex reprogramming of adult ovaries to testes by foxl2 ablation. Cell 139, 1130–1142 (2009).
Georges, A. et al. The transcription factor FOXL2 mobilizes estrogen signaling to maintain the identity of ovarian granulosa cells. eLife 3, e04207 (2014).
Bourdeau, V. et al. Genome-wide identification of high-affinity estrogen response elements in human and mouse. Mol. Endocrinol. 18, 1411–1427 (2004).
Piasecka, D. et al. FGFs/FGFRs-dependent signalling in regulation of steroid hormone receptors — implications for therapy of luminal breast cancer. J. Exp. Clin. Cancer Res. 38, 230 (2019).
Grynberg, M. et al. Differential regulation of ovarian anti-Müllerian hormone (AMH) by estradiol through α- and β-estrogen receptors. J. Clin. Endocrinol. Metab. 97, E1649–E1657 (2012).
Durlinger, A. L. L. et al. Anti-Müllerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology 143, 1076–1084 (2002).
Weenen, C. et al. Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol. Hum. Reprod. 10, 77–83 (2004).
Lv, Y. et al. In utero exposure to bisphenol A disrupts fetal testis development in rats. Environ. Pollut. 246, 217–224 (2019).
Jones, S. et al. Disruption of rat testis development following combined in utero exposure to the phytoestrogen genistein and antiandrogenic plasticizer di-(2-ethylhexyl) phthalate. Biol. Reprod. 91, 64 (2014).
Stewart, M. K., Mattiske, D. M. & Pask, A. J. Oestrogen regulates SOX9 bioavailability by rapidly activating ERK1/2 and stabilising microtubules in a human testis-derived cell line. Exp. Cell Res. 398, 112405 (2021).
Loke, J. et al. Mutations in MAP3K1 tilt the balance from SOX9/FGF9 to WNT/β-catenin signaling. Hum. Mol. Genet. 23, 1073–1083 (2014).
N’Tumba-Byn, T. et al. Differential effects of bisphenol A and diethylstilbestrol on human, rat and mouse fetal leydig cell function. PLoS ONE 7, e51579 (2012).
Jiang, D. D. et al. Effects of estrogen on spermatogenesis in transgender women. Urology 132, 117–122 (2019).
Leavy, M. et al. Effects of elevated β-estradiol levels on the functional morphology of the testis — new insights. Sci. Rep. 7, 39931 (2017).
Greene, R. R., Burrill, M. W. & Ivy, A. C. Experimental intersexuality: the relative sensitivity of male and female rat embryos to administered estrogens and androgens. Physiol. Zool. 15, 1–12 (1942).
Haavisto, T. et al. Prenatal testosterone and luteinizing hormone levels in male rats exposed during pregnancy to 2,3,7,8-tetrachlorodibenzo-p-dioxin and diethylstilbestrol. Mol. Cell. Endocrinol. 178, 169–179 (2001).
Christiansen, S. et al. Grouping of endocrine disrupting chemicals for mixture risk assessment — evidence from a rat study. Environ. Int. 142, 105870 (2020).
Rivas, A., Fisher, J. S., Mckinnell, C., Atanassova, N. & Sharpe, R. M. Induction of reproductive tract developmental abnormalities in the male rat by lowering androgen production or action in combination with a low dose of diethylstilbestrol: evidence for importance of the androgen-estrogen balance. Endocrinology 143, 4797–4808 (2002).
Prins, G. S. & Birch, L. The developmental pattern of androgen receptor expression in rat prostate lobes is altered after neonatal exposure to estrogen. Endocrinology 136, 1303–1314 (1995).
Buckley, J., Willingham, E., Agras, K. & Baskin, L. S. Embryonic exposure to the fungicide vinclozolin causes virilization of females and alteration of progesterone receptor expression in vivo: an experimental study in mice. Environ. Health 5, 4 (2006).
Elmelund, E. et al. Androgen receptor antagonist flutamide modulates estrogen receptor alpha expression in distinct regions of the hypospadiac rat penis. Front. Endocrinol. 16, 1654965 (2025).
Pande, P. et al. Comparative estrogenicity of endogenous, environmental and dietary estrogens in pregnant women II: total estrogenicity calculations accounting for competitive protein and receptor binding and potency. Food Chem. Toxicol. 125, 341–353 (2019).
Fleck, S. C. et al. Comparative estrogenicity of endogenous, environmental and dietary estrogens in pregnant women I: serum levels, variability and the basis for urinary biomonitoring of serum estrogenicity. Food Chem. Toxicol. 115, 511–522 (2018).
Hollier, L. P., Keelan, J. A., Hickey, M., Maybery, M. T. & Whitehouse, A. J. O. Measurement of androgen and estrogen concentrations in cord blood: accuracy, biological interpretation, and applications to understanding human behavioral development. Front. Endocrinol. (Lausanne) 5, 64 (2014).
Shutt, D. A., Smith, I. D. & Shearman, R. P. Oestrone, oestradiol-17β and oestriol levels in human foetal plasma during gestation and at term. J. Endocrinol. 60, 333–341 (1974).
Maner, D. F., Saffab, B. D., Wiggins, R. A., Thompson, J. D. & Preedy, J. R. K. Interrelationship of estrogen concentrations in the maternal circulation, fetal circulation and maternal urine in late pregnancy. J. Clin. Endocrinol. Metab. 23, 445–458 (1963).
Fukaya, T. et al. The human fetal prolactin and estradiol levels, and their correlationship. Tohoku J. Exp. Med. 143, 87–92 (1984).
Svingen, T. & Vinggaard, A. M. The risk of chemical cocktail effects and how to deal with the issue. J. Epidemiol. Community Health 70, 322–323 (2016).
Swislocki, A. L. M. & Eisenberg, M. L. A review on testosterone: estradiol ratio — does it matter, how do you measure it, and can you optimize it? World J. Mens Health 43, 453–464 (2025).
Harman, S. M., Metter, E. J., Tobin, J. D., Pearson, J. & Blackman, M. R. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J. Clin. Endocrinol. Metab. 86, 724–731 (2001).
Author information
Authors and Affiliations
Contributions
T.S., E.E., M.K.D., M.K.S. and D.M. researched data for the article. T.S., E.E., M.K.D. and A.J.P. contributed substantially to discussion of the content. All authors wrote the article. T.S., E.E., M.K.D. and A.J.P. reviewed and/or edited the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Reviews Urology thanks Anderson Andrade and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Elmelund, E., Draskau, M.K., Stewart, M.K. et al. Revisiting the dual role of androgens and oestrogens in mammalian sex differentiation with a focus on genitalia. Nat Rev Urol (2026). https://doi.org/10.1038/s41585-026-01132-z
Accepted:
Published:
Version of record:
DOI: https://doi.org/10.1038/s41585-026-01132-z


